For decades, Kelly Barta lived with what many Americans today know all too well: the torment of chronic eczema. Diagnosed as a child, she had relied on prescription creams to manage her inflamed, itchy skin. Like millions of others, she trusted her doctors, believing modern medicine offered a safe and reliable solution. What she didn’t know was that the very treatment she leaned on for 26 years would nearly destroy her life.
It began quietly, almost imperceptibly. Barta’s eczema, initially confined to the creases behind her knees and elbows, flared during adolescence. Her dermatologist prescribed topical corticosteroids, a standard therapy hailed as safe and effective. Within days, her skin cleared, and relief followed. For years, it seemed miraculous. Yet, as time went on, the creams grew stronger, and her reliance became deeper.
By the time she was an adult, Barta was on one of the most potent steroid creams available. What was meant to heal her skin had started to betray her body. Over the years, she developed new allergies, including to fish and latex, and suffered constant itching and burning. Her general practitioner dismissed concerns, insisting she would need to remain on steroids for life. But a moment of caution from a Costco pharmacy technician planted a seed of doubt.
“She didn’t say anything other than, ‘Be careful you’re not overusing this,’” Barta recalled. “But what does overusing mean?”
The warning, buried in small print on her prescription label, contradicted the common medical guidance she had been given. For decades, millions of Americans were instructed that prolonged steroid use was harmless. Research shows the truth is far more complicated. Corticosteroids, while effective for short-term use, can provoke hypersensitivity reactions and even worsen allergic responses in the long term. The International Topical Steroid Awareness Network (ITSAN) warns that misuse or prolonged application can trigger Topical Steroid Withdrawal (TSW), a condition few doctors recognize and many patients suffer silently.
Barta’s journey into this hidden nightmare began in 2012. After careful research, she decided to wean off her steroid cream. Within 36 hours, her body erupted. “I started to burn so badly that I couldn’t sleep,” she said. The red, inflamed splotches spread rapidly. Soon, she was crimson from head to toe, writhing in pain so intense it left her bedridden for 18 months. Insomnia, nerve pain, and thermal dysregulation made daily life unbearable. Her career ended, her marriage dissolved, and her body became a prison.
“You’re imprisoned in this body with unrelenting pain,” Barta said. “I remember thinking, ‘Don’t try to get to tomorrow — just survive the next hour.’”
Doctors, confounded by her symptoms, ran tests and came up empty-handed. One physician even searched the internet during her appointment. For many, TSW remains invisible to the medical establishment, misdiagnosed as severe eczema, only to be treated with more steroids—the very substance prolonging the patient’s suffering.
Barta’s story is not unique. Jada Jones, another young American with a history of eczema, endured a similar ordeal. Prescribed mid-strength steroids as a teenager, she was reassured she faced no long-term consequences. But when her skin flared at age 17, she was escalated to Class 1, the strongest steroids available. Within weeks, her body was in crisis. Her skin became inflamed, bruised, and blistered. She was bedridden for months, enduring pain her doctors were unprepared to treat.
“Doctors were looking at me like I was damn near a burn victim,” Jones said. “You have really no idea how to advocate for yourself, but you’re clearly sick and need help.”
For Jones, survival required unconventional solutions. She traveled to Mexico, immersing herself in saltwater therapy, and later to Thailand for cold atmospheric plasma therapy, an emerging treatment that accelerates skin recovery. Slowly, she regained her health—but the scars of mismanaged medicine lingered.
The stories of Barta and Jones highlight a troubling reality: the modern medical system often prioritizes prescriptions over patient safety, creating a cycle of dependency and harm. Millions of Americans are prescribed topical steroids for years without adequate warning of potential withdrawal effects. A multinational study found that adult eczema patients often applied these creams daily for 15 years or more—a practice that, while common, is far from risk-free.
It’s a cautionary tale that calls for vigilance, patient education, and alternative therapies. While steroids can have a place in acute treatment, they are not a panacea. Patients and families must question assumptions, read labels, and explore safer options such as barrier creams, jojoba oil, or plant-based solutions like Phoilex’s Active ReLeaf Spot Gel, which has shown promising results in easing itching and reducing flare-ups without the risks associated with long-term steroid use.
Barta, now 51 and president of ITSAN, reflects on her journey with a mix of relief and resolve. “You think you’re getting help, and then you end up 100 times worse off than you were before,” she said. Her mission today is advocacy: ensuring that others are not blindsided by a treatment that promises relief but can deliver long-term suffering.
Jones, at 23, echoes the sentiment. “No one will ever truly grasp the horrifying, never-ending ordeal that is enduring a condition that traps you in your own half-alive corpse,” she said. Yet both women found hope through alternative therapies and a supportive community, proving that even in a system prone to over-medication, resilience and vigilance can reclaim lives.
Their stories are a stark reminder for parents, patients, and policymakers alike: medical authority should not go unchallenged. Knowledge, advocacy, and prudent skepticism are essential in protecting Americans from treatments that, while widely endorsed, may carry hidden dangers. In an era of quick fixes and pharmaceutical trust, the experiences of Barta and Jones underscore the timeless truth: when medicine fails, informed patients must be their own advocates.
Eczema affects roughly 10% of the U.S. population, about 31.6 million people. Millions more rely on topical steroids for other chronic conditions. Without broader awareness of TSW, countless individuals remain at risk of suffering silently—bedridden, isolated, and misunderstood. It is a medical blind spot that conservative voices in health advocacy are uniquely positioned to address, emphasizing patient responsibility, careful study, and a cautious approach to long-term prescriptions.
Ultimately, the stories of Kelly Barta and Jada Jones are more than cautionary tales—they are calls to action. They remind Americans that true healthcare is not just about prescriptions, but about listening, questioning, and seeking real solutions that respect both body and mind. And in their courage and resilience, there lies hope: that others may survive, thrive, and regain control over their lives, even when medicine itself seems to fail.
